Galien Foundation

Galien Foundation The Galien Foundation fosters, recognizes and rewards excellence in scientific innovation that improves the state of human health.

Our mission is to serve as a vehicle for the open exchange of ideas that drive science and new innovations. Our vision is to catalyze the development of the next generation of innovative treatment and technologies that will improve health and save lives. Our scope is global, and our commitment to progress in medicine is both measurable and concrete. Our members express this through the establishme

nt of productive relationships to build lasting bridges between the commercial research enterprise and local communities engaged in public policy, science, finance, academic research and the media. Our non-profit 501(c)(3) Foundation oversees and directs activities in the United States for the Prix Galien, an international award that recognizes outstanding achievements in improving the human condition through the development of innovative therapies. Founded in France 50 years ago by pharmacist Roland Mehl in honor of Galen, the father of medical science and modern pharmacology, the Prix Galien supports, recognizes and awards the efforts of scientists, researchers and companies committed to advancing medical innovation with the power to change the human condition. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research.

Replay the second panel of the 2025   UK Forum "Advances In Individualised Medicine: Are Breakthrough Therapies For Ultr...
06/17/2025

Replay the second panel of the 2025 UK Forum "Advances In Individualised Medicine: Are Breakthrough Therapies For Ultra Rare Diseases Within Reach?: https://youtu.be/kQSbWmMPqH0?feature=shared

Chair: Dame June Raine, Former Chief Executive Officer, Medicines and Healthcare products Regulatory Agency

Speakers:
Prof. Matthew Wood, Professor of Neuroscience, Deputy Head Medical Sciences Division (Innovation), University of Oxford, Director and Chief Scientific Officer Oxford-Harrington Rare Disease Centre, Adjunct Professor of Medicine, Case Western Reserve University School of Medicine

Dr. Gregory Friberg, Chief Research & Development Officer, BioMarin Pharmaceutical

Dr. Janet Woodcock, Former Director of the Center for Drug Evaluation and Research and Principal Deputy Commissioner of the U.S. Food and Drug Administration

Dame Sue Hill, CSO for England, Senior Responsible Officer for Genomics in the NHS

Avril Daly, President of EURORDIS

PANEL 2: ADVANCES IN INDIVIDUALISED MEDICINE:ARE BREAKTHROUGH THERAPIES FOR ULTRA RARE DISEASES WITHIN REACH?Chair: Dame June Raine, Former Chief Executive O...

Replay the first panel of the 2025   UK Forum, "Advances In International HTA Collaboration: How Will Joint Clinical Ass...
06/16/2025

Replay the first panel of the 2025 UK Forum, "Advances In International HTA Collaboration: How Will Joint Clinical Assessments Impact Patient Access to Medicines in Europe?": https://youtu.be/hsEew9w1qLg?feature=shared

Chair: Dr. Mel Walker, Life Sciences Strategic Advisor and CEO, Access InVivo

Speakers:
Dr. Steffen Thirstrup, Chief Medical Officer at European Medicines Agency

Niklas Hedberg, Chief Pharmacist at the Swedish National Governmental Authority, the Dental and Pharmaceuticals Benefits Agency and Co-Chair, the EU Member States Coordination Group under HTAR

Dr. Sam Roberts, Chief Executive, NICE - National Institute for Health and Care Excellence

Valentina Strammiello, Director of Strategic Initiatives at the European Patients Global Forum on Research and Innovation for Health

Dr. Greg Rossi, Senior Vice President Head of Oncology Europe and Canada, AstraZeneca

PANEL 1: ADVANCES IN INTERNATIONAL HTA COLLABORATION:HOW WILL JOINT CLINICAL ASSESSMENTS IMPACT PATIENT ACCESS TO MEDICINES IN EUROPE?Chair: Dr. Mel Walker, ...

This year's   UK Lifetime Achievement Award was bestowed upon Dame June Raine, Former Chief Executive Officer, Medicines...
06/13/2025

This year's UK Lifetime Achievement Award was bestowed upon Dame June Raine, Former Chief Executive Officer, Medicines and Healthcare Products Regulatory Agency, for outstanding contributions to the UK health industry.

Watch now:

One week ago, we honoured and celebrated the latest cohort of innovators, leaders, and change-makers in the life science...
06/12/2025

One week ago, we honoured and celebrated the latest cohort of innovators, leaders, and change-makers in the life sciences at the UK Awards Ceremony. Congratulations once again to all nominees and winners who made this year's event such a momentous occasion.

Learn more: https://galien.org/4kBUbWQ

We are honoured to announce the 2025   UK Award winners, announced last night during a spectacular ceremony at Natural H...
06/06/2025

We are honoured to announce the 2025 UK Award winners, announced last night during a spectacular ceremony at Natural History Museum, London. Read the full announcement, here: https://galien.org/4kBUbWQ

The stage is set, and the winners have yet to be announced. Tomorrow, 5th June, we return to London for the annual   UK ...
06/04/2025

The stage is set, and the winners have yet to be announced. Tomorrow, 5th June, we return to London for the annual UK Forum and Awards Ceremony to unite leaders and innovators in the life sciences industries.

Learn more: https://www.galienfoundation.org/prix-galien-uk

The Prix Galien UK judging panel comprises numerous of the UK’s leading luminaries in healthcare, and is guided by the c...
06/03/2025

The Prix Galien UK judging panel comprises numerous of the UK’s leading luminaries in healthcare, and is guided by the conviction that acknowledging research-driven innovation is key to the improvement of healthcare in the UK and human health globally.

Visit the UK website and learn more: https://www.galienfoundation.org/prix-galien-uk

From exploring advances in treatment for obesity, to learning about how healthcare systems are addressing global mental ...
06/02/2025

From exploring advances in treatment for obesity, to learning about how healthcare systems are addressing global mental health/mood disorders, this year's UK Forum, hosted this Thursday, 5th June, promises to deliver a range of thought provoking discussions with industry leading experts.

Learn more about this year's agenda:

Don't miss galien forum UK 2025. See the program's keynotes, panels, and networking events. It's your chance to connect with top healthcare leaders.

The 2025   UK Forum & Awards Ceremony on June 5 is one week away! As we prepare to bring together industry leaders acros...
05/29/2025

The 2025 UK Forum & Awards Ceremony on June 5 is one week away! As we prepare to bring together industry leaders across the life sciences sectors to learn, network, and celebrate achievements at the industry's premier platform, we look forward to seeing you there.

Learn more: https://prixgalien.co.uk/

The second panel at the 2025   UK Forum, chaired by Dame June Raine, will explore "Advances in Individualised Medicine: ...
05/28/2025

The second panel at the 2025 UK Forum, chaired by Dame June Raine, will explore "Advances in Individualised Medicine: Are Breakthrough Therapies For Ultra Rare Diseases Within Reach?"

Learn more:

Don't miss galien forum UK 2025. See the program's keynotes, panels, and networking events. It's your chance to connect with top healthcare leaders.

Address

60 Broad Street
New York, NY
10004

Alerts

Be the first to know and let us send you an email when Galien Foundation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to Galien Foundation:

Share